668477-52-9

Basic information

• Product Name: Benzaldehyde, 2-ethyl-4-(phenylmethoxy)-
• CAS NO: 668477-52-9
• Molecular Formula: C16H16O2
• Molecular Weight: 240.302
• Mol File: 668477-52-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 2-ethyl-4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2-ethyl-4-(phenylmethoxy)-(668477-52-9)
• EPA Substance Registry System: Benzaldehyde, 2-ethyl-4-(phenylmethoxy)-(668477-52-9)

Safety Data

• Hazardous Substances Data: 668477-52-9(Hazardous Substances Data)

Upstream product

• 668477-51-8 4-(benzyloxy)-1-bromo-2-ethylbenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 100-39-0 benzyl bromide 
• 668477-50-7 1-(benzyloxy)-3-ethylbenzene 
• 620-17-7 3-ethylphenol 
• 2591-86-8 N-Formylpiperidine 
• 729590-49-2 4-bromo-3-propylbenzyloxybenzene 

Downstream Products

• 854532-15-3 C₂₀H₂₂O₃ 
• 729590-47-0 4-benzyloxy-2-ethyl-ethyl trans-cinnamate 
• 729590-51-6 4-benzyloxy-2-propyl-ethyl trans-cinnamate 
• 668477-53-0 (S)-4-benzyl-3-[(2S,3R)-3-(4-benzyloxy-2-ethyl-phenyl)-2-ethoxy-3-hydroxy-propionyl]-oxazolidin-2-one 
• 851334-65-1 4-(benzyloxy)-2-ethylbenzoic acid 

Relevant articles and documents

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS

The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS

The present invention relates to compounds of formula (I) wherein Rl to R10, X, Y and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.

SUBSTITUTED 4-ALKOXYOXAZOL DERIVATIVES AS PPAR AGONISTS

The present invention relates to compounds of formula (I) wherein R1 to R8 and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.